QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis 期刊论文 2019, 卷号: 37, 期号: 1, 页码: 143-153 作者:  Zhang, Jianzhong;  Li, Xiao;  Yang, Bin;  Wu, Cheng;  Fan, Yanghua 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Lower urinary tract symptom  Benign prostatic hyperplasia  Phosphodiesterase type 5 inhibitor  -Blocker   Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma? 期刊论文 Medicine (Baltimore), 2018, 卷号: Vol.97 No.3, 页码: e9601 作者:  Shijian Feng;  Liang Zhou;  Qinyu Liu;  Qing He;  Banghua Liao 收藏  |  浏览/下载：5/0  |  提交时间：2019/02/25 melanoma  phosphodiesterase type 5 inhibitor  risk factor  systematic review   A randomized clinical trial investigating treatment choice in Chinese men receiving sildenafil citrate and tadalafil for treating erectile dysfunction 期刊论文 2017, 卷号: 19, 期号: 4, 页码: 500-504 作者:  Bai, Wen-Jun;  Li, Hong-Jun;  Jin, Jian-Jun;  Xu, Wen-Ping;  Sebastian, Sorsaburu 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04 drug attributes  erectile dysfunction  phosphodiesterase type 5 inhibitor  psychological assessment of sexual dysfunction   Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction 期刊论文 International Journal of Gynecology & Obstetrics, 2016, 卷号: Vol.133 No.2, 页码: 139-145 作者:  Liang Gao;  Lu Yang;  Shengqiang Qian;  Tao Li;  Ping Han 收藏  |  浏览/下载：7/0  |  提交时间：2019/02/25 Female sexual dysfunction  Meta-analysis  Phosphodiesterase type 5 inhibitor (PDE5i)  Sildenafil